loe 908 has been researched along with hematoxylin in 1 studies
Studies (loe 908) | Trials (loe 908) | Recent Studies (post-2010) (loe 908) | Studies (hematoxylin) | Trials (hematoxylin) | Recent Studies (post-2010) (hematoxylin) |
---|---|---|---|---|---|
50 | 0 | 5 | 2,228 | 25 | 918 |
Protein | Taxonomy | loe 908 (IC50) | hematoxylin (IC50) |
---|---|---|---|
Chain E, Fibrin beta chain | Homo sapiens (human) | 9.328 | |
Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 17.36 | |
Mcl-1 | Homo sapiens (human) | 3.4393 | |
MPI protein | Homo sapiens (human) | 26.374 | |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 20.0467 | |
Vif | Human immunodeficiency virus 1 | 0.46 | |
Tat | Human immunodeficiency virus 1 | 11.696 | |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 0.46 | |
large T antigen | Betapolyomavirus macacae | 4.66 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christensen, T; Diemer, NH; Ensinger, HA; Wienrich, M | 1 |
1 other study(ies) available for loe 908 and hematoxylin
Article | Year |
---|---|
The broad-spectrum cation channel blocker pinokalant (LOE 908 MS) reduces brain infarct volume in rats: a temperature-controlled histological study.
Topics: Acetamides; Animals; Astrocytes; Blood Pressure; Body Temperature; Brain Infarction; Disease Models, Animal; Hematoxylin; Immunohistochemistry; Infusions, Intravenous; Isoquinolines; Male; Neuroglia; Rats; Rats, Wistar; Survival | 2005 |